Signet Ring Cells in Esophageal and Gastroesophageal Junction Carcinomas Have a More Aggressive Biological Behavior
Authors:
- Toni E. LerutTLToni E. Lerut
- Patrick J. VilleneuvePVPatrick J. Villeneuve
- Jeroen M. DhaenensJDJeroen M. Dhaenens
- Gert De HertoghGHGert De Hertogh
- Johnny MoonsJMJohnny Moons
- Willy J. CoosemansWCWilly J. Coosemans
- Hans G. Van VeerHVHans G. Van Veer
- Paul R. De LeynPLPaul R. De Leyn
- 1 December 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 260 (6) , 1023-1029
Abstract
To clarify the biologic behavior of esophageal signet ring cell (SRC) carcinomas of the esophagus and gastroesophageal junction (GEJ). To evaluate the accuracy of pretreatment biopsies in diagnosing true SRC carcinoma. In contrast with gastric cancer, little is known about the biologic behavior and prognosis of SRC. All adenocarcinomas (ADC) of the esophagus and GEJ-patients undergoing primary resection between 1990 and 2009 were included (n = 920). Specimens containing SRCs (n = 114) were classified according to World Health Organization criteria (>50% SRC or 50% (13.6%, P = 0.0001) compared with ADC. Complete resection was achieved in 86.5% of patients (n = 697) in ADC, 69.5% (n = 57) in SRC < 50%, and 78.1% (n = 25) in SRC > 50% (vs ADC, respectively, P < 0.0001 and P = 0.1801). In 379 pN + R0 patients, the median number of positive lymph nodes was comparable between ADC and SRC < 50% (4 vs 5, P = 0.207) or SRC > 50% (4 vs 8, P = 0.077). Compared with ADC, SRC > 50% showed more pN3's (30% vs 61%, P = 0.006), higher recurrence (56% vs 42% for ADC, P = 0.003), and local-regional recurrences (29% vs 16%, P = 0.002). Pretreatment biopsies were unreliable to define the presence of SRC > 50% (sensitivity = 56.3%, positive predictive value = 43.9%). SRCs are aggressive neoplasms associated with poorer prognosis than other ADCs after primary esophagectomy. Because our data suggest that pretreatment biopsies failed to reliably define presence of SRC > 50%, presence of SRCs in pretreatment biopsies seems to be of no use to define treatment strategy or prognosis.Keywords
This publication has 15 references indexed in Scilit:
- Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical PresentationAnnals of Surgery, 2009
- Predicting Individual Survival After Gastric Cancer ResectionAnnals of Surgery, 2006
- Individualised Surgical Treatment of Patients with an Adenocarcinoma of the Distal Oesophagus or Gastro-Oesophageal JunctionDigestive Surgery, 2005
- Quality in the surgical treatment of cancer of the esophagus and gastroesophageal junctionEuropean Journal of Surgical Oncology, 2005
- Survival After Gastric Adenocarcinoma Resection: Eighteen-Year Experience at a Single InstitutionJournal of Gastrointestinal Surgery, 2005
- Signet-Ring Cell or Mucinous Histology after Preoperative Chemoradiation and Survival in Patients with Esophageal or Esophagogastric Junction AdenocarcinomaClinical Cancer Research, 2005
- Clinicopathological characteristics of signet ring cell carcinoma of the stomachAnz Journal of Surgery, 2004
- Esophageal CancerNew England Journal of Medicine, 2003
- Dysplasia in Barrett’s Esophagus: Diagnosis, Surveillance and TreatmentDigestive Diseases, 1996
- Surgical Pathology of Adenocarcinoma Arising in Barrettʼs Esophagus Analysis of 67 CasesAmerican Journal of Surgical Pathology, 1995